Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Neier, Michelle
Pappo, Alberto
and
Navid, Fariba
2012.
Management of Melanomas in Children and Young Adults.
Journal of Pediatric Hematology/Oncology,
Vol. 34,
Issue. Supplement 2,
p.
S51.
Noguchi, Shunsuke
Mori, Takashi
Otsuka, Yusami
Yamada, Nami
Yasui, Yuki
Iwasaki, Junya
Kumazaki, Minami
Maruo, Kohji
and
Akao, Yukihiro
2012.
Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 Protein in Human Melanoma Cells.
Journal of Biological Chemistry,
Vol. 287,
Issue. 15,
p.
11769.
Dietel, M.
Enk, A.
Lehmann, A.
Bauer, J.
Garbe, C.
Kellner, U.
Kirchner, T.
Jung, A.
Kreipe, H.
Merkelbach-Bruse, S.
Büttner, R.
Rüschoff, J.
Schlake, W.
Schirmacher, P.
Penzel, R.
and
Stadler, R.
2012.
BRAF-Mutationstestung beim metastasierten malignen Melanom.
Der Pathologe,
Vol. 33,
Issue. 4,
p.
352.
De Mello, Ramon Andrade
2012.
Metastatic Melanoma and Vemurafenib: Novel Approaches.
Rare Tumors,
Vol. 4,
Issue. 2,
p.
96.
Kozubek, James
Ma, Zhihai
Fleming, Elizabeth
Duggan, Tatiana
Wu, Rong
Shin, Dong-Guk
Dadras, Soheil S.
and
Slominski, Andrzej T.
2013.
In-Depth Characterization of microRNA Transcriptome in Melanoma.
PLoS ONE,
Vol. 8,
Issue. 9,
p.
e72699.
Orecchia, Paola
Conte, Romana
Balza, Enrica
Petretto, Andrea
Mauri, PierLuigi
Mingari, Maria Cristina
and
Carnemolla, Barbara
2013.
A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma.
European Journal of Cancer,
Vol. 49,
Issue. 8,
p.
2022.
Madhunapantula, SubbaRao V.
Sharma, Arati
Gowda, Raghavendra
and
Robertson, Gavin P.
2013.
Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma.
Pigment Cell & Melanoma Research,
Vol. 26,
Issue. 6,
p.
886.
Noguchi, Shunsuke
Iwasaki, Junya
Kumazaki, Minami
Mori, Takashi
Maruo, Kohji
Sakai, Hiroki
Yamada, Nami
Shimada, Kazuyuki
Naoe, Tomoki
Kitade, Yukio
and
Akao, Yukihiro
2013.
Chemically Modified Synthetic microRNA-205 Inhibits the Growth of Melanoma Cells In Vitro and In Vivo.
Molecular Therapy,
Vol. 21,
Issue. 6,
p.
1204.
Pakneshan, Sahar
Salajegheh, Ali
Anthony Smith, Robert
and
King-Yin Lam, Alfred
2013.
Clinicopathological relevance of BRAF mutations in human cancer.
Pathology,
Vol. 45,
Issue. 4,
p.
346.
Dianzani, Chiara
Zara, Gian Paolo
Maina, Giovanni
Pettazzoni, Piergiorgio
Pizzimenti, Stefania
Rossi, Federica
Gigliotti, Casimiro Luca
Ciamporcero, Eric Stefano
Daga, Martina
and
Barrera, Giuseppina
2014.
Drug Delivery Nanoparticles in Skin Cancers.
BioMed Research International,
Vol. 2014,
Issue. ,
p.
1.
Plötz, Michael
and
Eberle, Jürgen
2014.
BH3‐only proteins – possible proapoptotic triggers for melanoma therapy.
Experimental Dermatology,
Vol. 23,
Issue. 6,
p.
375.
Daphu, Inderjit
Horn, Sindre
Stieber, Daniel
Varughese, Jobin
Spriet, Endy
Dale, Hege
Skaftnesmo, Kai
Bjerkvig, Rolf
and
Thorsen, Frits
2014.
In Vitro Treatment of Melanoma Brain Metastasis by Simultaneously Targeting the MAPK and PI3K Signaling Pathways.
International Journal of Molecular Sciences,
Vol. 15,
Issue. 5,
p.
8773.
Xu, Sanxiong
Yang, Zuozhang
Zhang, Jinyu
Jiang, Yongxin
Chen, Yongbin
Li, Hongjun
Liu, Xuefeng
Xu, Da
Chen, Yanjin
Yang, Yihao
Zhang, Ya
Li, Dongxu
and
Xia, Junfeng
2015.
Increased Levels of β-catenin, LEF-1, and HPA-1 Correlate with Poor Prognosis for Acral Melanoma with Negative BRAF and NRAS Mutation in BRAF Exons 11 and 15 and NRAS Exons 1 and 2.
DNA and Cell Biology,
Vol. 34,
Issue. 1,
p.
69.
Urban, Jennifer
Bayart, Cheryl B.
Taylor, John A.
Hegde, Upendra
Forouhar, Faripour
and
Dadras, Soheil S.
2016.
Urethral duct invasion in female urethral melanoma.
Human Pathology: Case Reports,
Vol. 6,
Issue. ,
p.
48.
Brys, Adam K.
Gowda, Raghavendra
Loriaux, Daniel B.
Robertson, Gavin P.
and
Mosca, Paul J.
2016.
Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy.
Biotechnology Advances,
Vol. 34,
Issue. 5,
p.
565.
2017.
Diagnostic Pathology: Neoplastic Dermatopathology.
p.
864.
Fang, Wei
Fan, Yibin
Fa, Zhenzong
Xu, Jinhua
Yu, Hongyu
Li, Pu
and
Gu, Julin
2017.
microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma.
Oncotarget,
Vol. 8,
Issue. 8,
p.
13253.
Mota, Ana Henriques
Rijo, Patrícia
Molpeceres, Jesús
and
Reis, Catarina Pinto
2017.
Broad overview of engineering of functional nanosystems for skin delivery.
International Journal of Pharmaceutics,
Vol. 532,
Issue. 2,
p.
710.
2017.
Diagnostic Pathology: Neoplastic Dermatopathology.
p.
870.
Liu, Ke
Jin, Junjun
Rong, Kunjie
Zhuo, Lukai
and
Li, Pingsong
2017.
MicroRNA‑675 inhibits cell proliferation and invasion in melanoma by directly targeting metadherin.
Molecular Medicine Reports,